New Treatments for Myelodysplastic Syndromes


In the last decade, significant advances have been made in the treatment of patients with Myelodysplastic Syndromes (MDS). Although best supportive care continues to have an important role in the management of MDS, to date the therapeutic approach is diversified according to the IPSS risk group, karyotype, patient's age, comorbidities, and compliance… (More)
DOI: 10.4084/MJHID.2010.021


1 Figure or Table

Slides referencing similar topics